Abstract:Background: Numerous studies proved that long non-coding RNA (lncRNA) is involved in the progression of multifarious diseases, especially in some carcinomas. As a potential tumor biomarker, plasmacytoma variant translocation 1 gene (PVT1) is involved in the development and progression of multifarious cancers. Nevertheless, the intrinsic and concrete molecular mechanism of PVT1 in bladder cancer still remained unclear, which is also the dilemma faced in many non-coding RNA studies. Results: Our research revealed that PVT1 was significantly higher expression in bladder carcinoma specimens and cell lines. Further experiments indicated that knockdown or overexpression of PVT1 restrained or promoted the malignant phenotype and WNT/beta-catenin signaling in bladder cancer cells. Meanwhile miR-194-5p was in contrast and miR-194-5p could partially reverse the function of PVT1 in malignant bladder tumor cells. As a microRNA sponge, PVT1 actively promotes the expression of b-cells lymphoma-2-associated transcription factor 1 (BCLAF1) to sponge miR-194-5p and subsequently increases malignant phenotypes of bladder cancer cells. Therefore, it performs a carcinogenic effect and miR-194-5p as the opposite function, and serves as an antioncogene in the bladder carcinomas pathogenesis. Conclusion: PVT1-miR-194-5p-BCLAF1 axis is involved in the malignant progression and development of bladder carcinomas. Experiments revealed that PVT1 has a significant regulatory effect on bladder cancer (BC) and can be used as a clinical diagnostic marker and a therapeutic molecular marker for patients suffering from BC. Methods: In urothelial bladder carcinoma specimens and cell lines, the relative expression levels of PVT1 and miR-194-5p were detected by quantitative reverse transcription PCR (RT-qPCR). Through experiments such as loss-function and over-expression, the biological effects of PVT1 and miR-194-5p on the proliferation, migration, apoptosis and tumorigenicity were explored in bladder cancer cells. Co-immunoprecipitation, proteomics experiments, dual luciferase reporter gene analysis, western blot and other methods were adopted to investigate the PVT1 potential mechanism in bladder carcinomas.

LncRNA00518 Promotes Cell Proliferation Through Regulating Mir-101 in Bladder Cancer.

MiR-362-5p, Which is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI

LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer

Long Non‑coding RNA 00858 Knockdown Alleviates Bladder Cancer Via Regulation of the Mir‑3064‑5p/ctgf Axis.

LncRNA CASC15 Functions As an Oncogene by Sponging Mir-130B-3p in Bladder Cancer.

Upregulation of Long Non-Coding RNA ROR1-AS1 Promotes Cell Growth and Migration in Bladder Cancer by Regulation of Mir-504

LINC00461 promotes bladder cancer cells EMT through miR-518b/HNRNPUL1 axis

LINC00511/miRNA-143-3p Modulates Apoptosis and Malignant Phenotype of Bladder Carcinoma Cells via PCMT1

lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.

Alteration of lncRNA RHPN1-AS1 predicts clinical prognosis and regulates the progression of bladder cancer via modulating miR-485-5p

Long Non-Coding Rna Xist Promotes Cell Growth And Metastasis Through Regulating Mir-139-5p Mediated Wnt/Beta-Catenin Signaling Pathway In Bladder Cancer

High LINC00536 Expression Promotes Tumor Progression and Poor Prognosis in Bladder Cancer

Mir-135a Enhances Cellular Proliferation Through Post-Transcriptionally Regulating PHLPP2 and FOXO1 in Human Bladder Cancer

LINC00460 Enhances Bladder Carcinoma Cell Proliferation and Migration by Modulating miR-612/FOXK1 Axis

LncRNA SPRY4-IT1 Sponges Mir-101-3p to Promote Proliferation and Metastasis of Bladder Cancer Cells Through Up-Regulating EZH2.

Correction For: LncRNA PVT1 Accelerates Malignant Phenotypes of Bladder Cancer Cells by Modulating Mir-194-5p/bclaf1 Axis As a Cerna

LncRNA LINC00115 facilitates lung cancer progression through miR ‐607/ ITGB1 pathway

LncRNA ITGB1 Promotes the Development of Bladder Cancer Through Regulating Microrna-10A Expression

CCND1, NOP14 and DNMT3B Are Involved in Mir‐502‐5p–mediated Inhibition of Cell Migration and Proliferation in Bladder Cancer

Oncogene Mir-187-5p is Associated with Cellular Proliferation, Migration, Invasion, Apoptosis and an Increased Risk of Recurrence in Bladder Cancer.

Overexpression of Mirna-93-5p Promotes Proliferation and Migration of Bladder Urothelial Carcinoma Via Inhibition of KLF9